L. Hofstra

Intraperitoneal chemotherapy in ovarian cancer.

N. Mulder, E. de Vries, P. Willemse, 2000, Cancer treatment reviews.

To appreciate fully the indications and timing of tracheotomies.

J. Tulleken, J. Zwaveling, L. Hofstra, 2005, Critical care medicine.

Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.

F. Spijkervet, N. Mulder, E. de Vries, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.

E. D. de Vries, B. Kiese, H. Meden, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transient versus Persistent Acute Kidney Injury and the Diagnostic Performance of Fractional Excretion of Urea in Critically Ill Patients

A. Abu-Hanna, M. Kuiper, P. Spronk, 2014, Nephron Clinical Practice.

Serum cystatin C-A useful endogenous marker of renal function in intensive care unit patients at risk for or with acute renal failure?

M. Kuiper, P. Spronk, M. Schultz, 2007, Current medicinal chemistry.

Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.

J. Ligtenberg, J. Zijlstra, T. S. van der Werf, 2005, The Netherlands journal of medicine.

Associations between dynamics of the blood glucose level after hypoglycemia and intensive care unit mortality: a retrospective multicenter study

A. Abu-Hanna, M. Kuiper, J. Binnekade, 2015, Intensive Care Medicine.

Prevalence and management of delirium in intensive care units in the Netherlands: An observational multicentre study.

A. Slooter, K. Simons, E. Wils, 2020, Intensive & critical care nursing.

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy

M. Kuiper, J. Korevaar, P. Spronk, 2010, Intensive Care Medicine.

Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial

S. Houterman, P. V. D. van der Voort, A. Karakus, 2018, JAMA.